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ABSTRACT
Gut microbiota has been the subject of various molecular studies mainly due to its 
importance and wide-ranging relationships with human hosts. However, the storage of fecal 
samples prior to DNA extraction is critical when characterizing the composition of intestinal 
microbiota. Therefore, we aimed to understand the effects of different fecal storage methods 
to characterize intestinal microbiota using Next Generation Sequencing (NGS) as well as to 
establish an alternative conservation method of bacterial genetic material in these samples 
using guanidine. Stool samples from 10 healthy volunteers were collected. Each sample 
was divided into five aliquots: one aliquot was extracted immediately after collection (fresh) 
and two aliquots were subjected to freezing at -20 °C or -80 °C and extracted after 48 h. 
The other two aliquots were stored in guanidine at room temperature or 4 °C and extracted 
after 48 h. The V4 hypervariable regions of the bacterial and archeal 16S rRNA gene were 
amplified by PCR and sequenced using an Ion Torrent PGM platform for NGS. The data 
were analyzed using QIIME software. Statistical significance was determined using a non-
parametric Kruskal-Wallis test. A total of 11,494,688 reads with acceptable quality were 
obtained. Unweighted principal coordinate analysis (PCoA) revealed that the samples were 
clustered based on the host rather than by the storage group. At the phylum and genus levels, 
we observed statistically significant differences between two genera, Proteobacteria (p=0.013) 
and Suterella (p=0.004), comparing frozen samples with guanidine-stored samples. Our data 
suggest that the use of guanidine can preserve bacterial genetic materials as well as freezing, 
providing additional conveniences.
KEYWORDS: Next Generation Sequencing. Stool storage method. Microbiota. Gut 
microbiota
INTRODUCTION
Intestinal microbiota includes roughly 500 different species of bacteria in the 
human colon; the density of species can reach 1012 cells/mL, and Bacteroides 
as well as Firmicutes phyla are the most commonly reported1. There are up to 
100 trillion microbes in the gut with a genetic diversity 100-fold greater than that 
of the human genome2. Because of its enormous complexity, intestinal microbiota 
plays a crucial role in the health of the digestive system and the health of the human 
host via direct impacts on nutrient absorption, pathogen protection, and modulation 
of the immune system3.
Several clinical conditions that relate to changes in intestinal microbiota such 
as non-alcoholic fatty liver disease4, type I and type II diabetes5,6, inflammatory 
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bowel disease7, and obesity8 have been described. Intestinal 
microbiota, due to their importance and wide-ranging 
relationships with human hosts, has been the target of 
several molecular and culture-based studies2. Fecal samples 
do not require biopsy and are collected by a non-invasive 
procedure. These samples contain exfoliated epithelial cells 
that may include relevant information about the microbiota 
of the gastrointestinal tract9. Therefore, this study compared 
the gut bacteria proportion to determine the best stool 
storage method for microbiome studies.
MATERIAL AND METHODS 
Ethics
Fecal samples were collected from 10 healthy 
participants between the ages of 23 and 49 (mean age: 
36 years; standard deviation: 13.2 years). The majority 
had at least a bachelor’s degree (70%), and all of the 
individuals were non-Hispanic caucasians. None of the 
individuals had used antibiotics for at least a month. All of 
the procedures involving human subjects were approved 
by the Internal Review Board of the University of Sao 
Paulo (Comissao de Etica para Analise de Projetos de 
Pesquisa – CAPPesq), process Nº 12801. The participants 
provided written informed consent, which was securely 
stored in our laboratory according to Brazilian research 
policies.
Collection and storage of stool samples
We used the Fisherbrand™ Commode Specimen 
Collection System (ThermoFisher, Waltham, Massachusetts, 
USA) to collect the stool samples that were processed up 
to 1 h after collection. 
In the laboratory, the samples were weighed and 
separated into five different aliquots (20 g each). One 
aliquot was submitted to DNA extraction immediately after 
collection, and two aliquots were stored at -20 °C and -80 °C 
and the DNA was extracted after 48 h. The two remaining 
aliquots were maintained in a 6 M guanidine HCl-0.2 M 
EDTA solution, one at room temperature (RT) and the other 
at 4 °C and DNA was extracted after 48 h.
DNA extraction 
The genomic DNA extraction was performed using 
a Power Soil DNA Isolation Kit® (Mobio Laboratories, 
Carlsbad, CA, USA) with modifications. This procedure 
enabled a more efficient extraction of DNA from stool 
samples in a manner consistent with that performed by the 
Human Microbiome Project10. Briefly, the sample tubes 
were heated for 10 min at 65 °C, 10 min at 95 °C and then 
centrifuged for 2 min after the addition of C3 solution. All 
other steps were performed according to the manufacturer’s 
instructions. 
Library preparation and 16S sequencing
The V4 variable region of the 16S rRNA gene was 
amplified using the primers 515F (5′-GTGCCAGCM 
GCCGCGGTAA-3′) and 806R (5′-GGACTACHVGG
GTWTCTAAT-3′)11. These primers were designed to 
include the adaptor sequences used in the Ion Torrent 
NGS library preparation protocol containing the barcode 
sequence on the forward primer. The samples were 
normalized to 12.5 ng/μL of DNA material per library, 
and the amplification was performed in Veriti 96-well 
PCR equipment (ThermoFisher, Waltham, Massachusetts, 
USA) followed by AMPure XP bead cleanup (Beckman 
Coulter Life Sciences, Brea, California, USA). PCR 
conditions were 94 °C for 3 min, followed by 40 cycles 
of denaturation at 94 °C for 30 s, annealing at 58 °C for 
30 s and extension at 68 °C for 1 min. PCR products were 
analyzed by 1.5% agarose gel electrophoresis, stained 
with ethidium bromide solution and visualized under 
ultraviolet light. Emulsion PCR was carried out using 
an Ion PGM™ Template OT2 400 Kit (ThermoFisher, 
Waltham, Massachusetts, USA) in accordance with the 
manufacturer’s instructions. Sequencing of the amplified 
products was carried out using the Ion PGM™ Sequencing 
400 Kit in an Ion Torrent TM Personal Genome Machine 
(ThermoFisher, Waltham, Massachusetts, USA) using 
an Ion 318TM chip kit v2 (ThermoFisher, Waltham, 
Massachusetts, USA) with 16 libraries per chip. All 
samples were sequenced once.
Data analysis
Sequences were processed using the latest version 
of the Ion Torrent server (version 5.0.4). This procedure 
removes low quality and polyclonal sequences by filtering. 
The resulting reads were used as an input into the Qiime 
(Quantitative Insights into Microbial Ecology) software 
package (version 1.8)12 according to the Brazilian 
Microbiome Project13. Reads were grouped into operational 
taxonomic units (OTUs) based on 97% identity using 
UCLUST UPARSE (version 7)14. The representative 
sequences were then classified by taxonomy using the 
Greengenes database version 13.815 as a reference on Qiime. 
Taxonomy was added to the OTU table using the set of 
scripts found at http://biom-format.org/. 
Rev Inst Med Trop São Paulo. 2018;60:e77
An alternative storage method for characterization of the intestinal microbiota through next generation sequencing
Page 3 of 11
Statistical analyses
The species richness/diversity lost during storage was 
assessed by comparing each storage method (i.e., -80 °C, 
-20 °C, guanidine +4 °C and guanidine RT) with the control 
(fresh sample). For the alpha diversity, we used pairwise 
comparisons for observed OTUs, the Shannon diversity 
index, the Chao1 richness estimate and Simpson’s diversity 
index. For beta diversity, we calculated weighted and 
unweighted Unifrac distance matrices. 
To describe the microbial populations among the five 
storage groups, samples were combined according to the 
type of extraction method (using 13,000 reads for each 
sample). Then, the proportion of each taxonomic group 
was analyzed using the non-parametric Kruskal-Wallis test. 
All analyses were performed using the GraphPad Prism 
6 statistical software (Company, Location). A p-value of 
<0.05 (pc) was considered statistically significant after the 
Bonferroni correction for multiple tests.
RESULTS 
Participants were healthy adults with age varying 
from 23 to 49 years old and a mean age of 36 (standard 
deviation, 13.2) years. The majority had at least a bachelor 
degree (70%) and was non-Hispanic caucasians (100%). 
No participants had used antibiotics in the month before 
the fecal sample collection (Table 1). A total of 11,494,688 
reads with acceptable quality were obtained after the 
application of filters using the Torrent Browser software, 
generating an average of 229,894 reads (45,343+-±29,381 
[mean+-SD] sequences per sample).
The number of sequence reads did not differ significantly 
as a function of the collection method (Table 2; p = 0.825).
Regarding the five main phyla, Bacteroidetes and 
Firmicutes were the most representative. The proportion 
of Bacteroidetes observed among fresh samples was 42%, 
and in samples subjected to freezing at -20 °C and -80 °C 
36% and 39% Bacteroidetes, respectively (Figure 1A). The 
Proteobacteria phylum exhibited significant differences 
in proportion as a function of storage (p=0.019), but these 
differences did not persist after the Bonferroni correction 
(p
c
=0.095). Similar trends were observed comparing 
frozen samples with stored guanidine ones (Supplementary 
Table 1).
Clostridia (48%) and Bacteroidia (42%) were the 
most common classes (Figure 1B), but there were no 
significant differences between them (p=0.512 and 0.630, 
respectively). Despite its low frequency, Betaproteobacteria 
showed statistically significant results (p
c
=0.048), however, 
no significant differences were observed when groups were 
compared separately (Supplementary Table 2).
At the family level,  Bacteroidaceae  (31%), 
Lachnospiraceae (23%), and Ruminococcaceae (19%) 
were the most prevalent (Figure 1C) but did not exhibit 
statistically significant differences between groups 
(Supplementary Table 3).
The genera Bacteroides, Faecalibacterium, Prevotella, 
and Ruminococcus were the most common (Figure 1D). 
Only the genus Suterella exhibited a statistically significant 
difference (p
c
=0.108) as a function of storage conditions 
(Supplementary Table 4).
The alpha diversity indices, Chao1 richness estimate, 
observed species richness, and Shannon and Simpson 
diversity indices was used to determine whether alterations 
in microbial diversity occurred because of different fecal 
storage conditions. The rarefaction graph of the observed 
species indicated that the number of analyzed readings in 
the microbiota did not facilitate complete determination of 
the existing diversity. However, the slope of the curve was 
Table 2 - Filtered sequence reads according to the fecal 
samples storage method
Storage method Filtered sequence reads (mean+-SD)*
Method 1: fresh 49.864 (32.347)
Method 2: -20ºC 40.876 (32.721)
Method 3: -80ºC 50.399 (28.807)
Method 4: guanidine 4ºC 40.356 (22.015)
Method 5: guandine RT 45.222 (28.178)
RT: room temperature; *Kruskal-Wallis test (p=0.825)







High school or less 3 30
Bachelor degree 3 30
Master or Doctoral degree 4 40
Ethnicity
Non-Hispanic caucasian 10 100
BMI 33 (11.3)*
*Data are expressed as mean (standard deviation). BMI: body 
mass index.
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Figure 1 - Relative abundance of bacteria represented by OTUs in different sample storage conditions according to: 1A – Phyla; 
1B – Class; 1C – Family; 1D –Genera.
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modified at the point related to the approximate number 
of 1,000 reads (Figure 2). In summary, the alpha diversity 
analysis did not exhibit significant differences between 
storage groups (Table 3).
Diversity analysis of the intestinal microbiota was 
related to different taxonomic units and their phylogenetic 
relationships (Unifrac weighted) as a function of storage 
conditions. Unifrac wnweighted via principal coordinate 
analysis (PCoA) was not considered. The variation 
explained by the variables in the various axes of PCoA 
associated with the unweighted Unifrac analyses was 
less than 20%. However, even with this low variation, 
one could see that the samples were grouped according 
to the individuals (Figure 3A). All five samples from 
the one individual clustering were more closely related 
than the other samples from the same storage group 
(Figure 3B).
When we considered the relative abundance of OTUs 
from the comparative diversity analysis of the samples via 
the unbalanced Unifrac method, we noted a higher variation 
of results than among the ones based on the unweighted 
Unifrac method. The variation explained in the several axes 
of the main coordinate graph was 51% in the PC1 axis and 
14% in the PC2 axis. However, the samples were grouped 
with greater proximity based on the individuals analyzed 
rather than with samples from the same storage group (data 
not shown).
DISCUSSION
There were no differences between the storage protocols 
and the overall microbiota composition. Our results showed 
no differences among the relative abundance of the bacteria 
when comparing fresh, frozen at -20 °C or -80 °C, and 
samples stored in guanidine at 4 °C and at RT. However, 
differences were observed between samples from different 
individuals rather than different stool storage methods.
Bacterial abundances were evaluated for each sample. 
When the relative abundance of the phylum Proteobacteria 
and the family Alcaligenaceae were evaluated for all 
conditions,there was no difference between fresh samples 
and samples stored in guanidine solution at either RT or 
at 4 °C for 48 h. However, there were differences in the 
relative abundance between frozen samples and samples 
Table 3 - Alpha-Diversity estimation of fresh samples: -20 ºC frozen; -80 ºC frozen; guanidine at 4 °C and guanidine at room 
temperature
Fresh Frozen - 20ºC Frozen - 80ºC Guanidine 4ºC Guanidine room temperature p-value
Chao1 richness estimate 302 331 318 318 325 0.996
Shannon index 5.26 5.33 5.32 5.21 5.32 0.988
Simpson's diversity index 0.93 0.93 0.93 0.93 0.94 0.916
Number of observed species 241 258 258 244 257 0.901
Figure 2 - Alpha Rarefaction Index - Number of observed 
species graph.
Figure 3 - PCoA analysis based on unweighted UniFrac 
distance matrices. Section A: samples by subject ID. Section B: 
samples by storage method.
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stored in guanidine solution. Studies have shown that 
despite a low prevalence in the gut, an increase in the 
phylum Proteobacteria may be associated with dysbiosis, 
i.e., a higher risk of developing diseases16. Therefore, it 
is important not to underestimate the prevalence of these 
bacteria. 
Higher but not significant levels of Firmicutes were 
noted in samples stored for 48 h at -20 °C and -80 °C 
compared to fresh samples. This result supports the findings 
of previous studies that demonstrated a higher proportion 
of Firmicutes in frozen samples compared to fresh ones17. 
Samples stored in guanidine for 48 h had lower levels of 
phylum Firmicutes than those found in fresh samples; 
however, the differences were not statistically significant.
The bacterial diversity related to alpha and beta diversity 
analysis after 48 h of storage showed no significant 
differences compared to fresh samples. Previously, studies 
using the pyro-sequencing technique and the Illumina 
MiSeq platform demonstrated that frozen samples were 
grouped based on the volunteers rather than on the storage 
protocol17,18.
Here, we propose an alternative method to maintain the 
microbiota DNA integrity using a solution of 6 M guanidine/
EDTA19,20 as RNA later21 and other preservative buffers are 
cost prohibitive for field studies.The guanidine method , 
along with other alternative ones including OMNIgene, 
GUT, Tris-EDTA22, ethanol and lyophilization23, makes 
these studies feasible.
Several reports have indicated the importance of 
conservation and storage of samples for evaluation of fecal 
microbiota21,24,25. It is widely accepted that immediate 
processing or freezing of stool samples are the best way to 
maintain bacterial DNA integrity26. Immediate freezing at 
-20 °C or below has been considered the gold standard for 
microbiome preservation27. This approach is not feasible 
in many field studies, however, storing samples at RT for 
long periods of time may alter microbiota composition28. 
Alternative storage conditions, which keep bacterial DNA 
intact, are imperative for microbiota studies through 
Next Generation Sequencing. Recent studies28,29 have 
shown that test cards for fecal occult blood screening 
may be a good alternative for stool sample conservation. 
Vlčková et al.21 showed that ethanol is a good alternative 
for Enterobacteriaceae preservation. However, the use of 
ethanol in microbiota studies must be carefully evaluated 
because certain types of bacteria can be sensitive to ethanol. 
Although preservative buffers may alter fecal microbiota22, 
they should be considered in field studies30 when freezing of 
samples is not feasible. A sample stored at RT prior to DNA 
extraction may also exhibit degradation and altered relative 
bacterial abundances at the time of analysis25. As noted by 
Kia et al.31, sample integrity can be preserved for years if 
they are appropriately stored after DNA extraction. Besides 
immediately frozen samples, another alternative would be 
to homogenize the samples prior to DNA extraction, which 
may also improve the quality of microbiome analysis32. 
Several studies have demonstrated the importance of 
samples conservation and storage procedures to evaluate 
fecal microbiota. A study using 16S rRNA gene pyrolysis 
technology revealed that the phylogenetic structure of feces 
microbiota does not change significantly when samples are 
stored at various temperatures over 3-14 days31. However, 
this study did not include samples obtained immediately 
after defecation. Therefore, it is possible that the intestinal 
microbiota has quickly degraded and consequently 
maintained this composition over this time. In another study 
using pyrosequencing, stool samples stored at -80 °C for 
six months exhibited microbial compositions and diversities 
more similar to those of samples processed within 30 min 
after defecation33.
The use of chemical preservatives, as proposed here, 
should be evaluated for each application because different 
bacteria may exhibit different levels of sensitivity to these 
preservatives.
 Although our study only assessed storage conditions of 
fecal samples over a short period of time, other studies have 
examined samples over longer time periods and found no 
significant changes in intestinal microbiota17,34. However, 
we expect to continue to study these fecal samples for 
months and even years as a function of storage methods 
using the next-generation Ion Torrent PGM sequencing 
platform. This work will answer questions about long-term 
storage.
One of the possible limitations of our study is that 
participants were healthy. Therefore, we could not asses the 
effect of highly dysbiotic microbiota on different collection 
methods. In contrast, previous studies have included patients 
with irritable bowel syndrome and inflammatory bowel 
disease35,36. In general, even in these studies, differences 
were not observed between different groups; this finding 
was independent of the collection material. The number of 
studied individuals may have also contributed to the fact 
that no statistically significant differences were observed. 
Even using rarefaction plots, we were unable to reach all 
OTUs in the samples after more than 13,000 reads. The 
Shannon index exhibited low variability in the estimated 
diversity among the samples analyzed in the different 
storage conditions, probably contributing to the lack of 
discriminatory power of the rarefaction plots.
Multiple factors must be taken into account in 
microbiome studies, including DNA integrity. Here, the 
gel electrophoresis exhibited minimal degradation for all of 
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the analyzed samples. A study by Cardona et al.25 showed 
degradation of fecal sample DNA after storage at RT for 
3 h. We were unable to examine this specific point because 
our samples were stored at RT for no more than 30 min. 
In contrast, Guo et al.37 reported no difference in alpha 
diversity for stool storage at RT up to 2 h, and Shaw et al.38 
also showed significant changes in the microbial community 
after only 2 days of storage at RT. Differences in extraction 
methods may alter DNA yields, independent of the sample 
type (fresh or frozen). Furthermore, storage conditions may 
adversely affect the main phyla, which are frequently used 
as biomarkers of gut microbiota24. The bacterial region, 
as well as the methods used to detect them, is also very 
important. The 16S bacterial RNA gene has been used to 
determine bacterial microbiota39 and the V4 region of the 
16S gene, used in this study, is commonly sequenced to 
identify bacterial species40 due to its highly conserved and 
hypervariable regions, which confers a signature sequence 
that is species-specific. 
Prior studies used methods ranging from simple 
amplification of the 16S RNA gene by PCR to Next 
Generation Sequencing, which we also used. Semiconductor 
sequencing has known limitations, including pairing errors 
and homopolymer detection. These limitations must be 
taken into account depending on the type of study that has 
been performed41,42. A number of approaches, including 
optimization of the bioinformatics pipeline and increased 
depth of coverage, are generally used in analyses based on 
this type of method that seek to overcome the shortcomings 
of the Ion Torrent platform43. In addition, this study only 
evaluated the bacterial 16S rRNA gene. Future studies, 
including those focusing on shotgun sequencing, should 
consider the effect of collection methods on the analyses.
Our results suggest that guanidine can conserve fecal 
samples for microbiome studies if freezing is not possible 
or is troublesome. Using guanidine for the collection and 
storage of stool samples in microbiome studies allows 
researchers to avoid using dry ice in the field, also reducing 
the need of -20 °C and -80 °C freezers. Room-temperature 
storage can remove possible interferers, such as problems 
associated with freezing/thawing cycles. Finally, this type 
of sample collection can enable collaborative studies that 
span laboratories across different geographic locations. 
These studies might reduce the effects of sample collection 
and could reduce the associated costs. 
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Supplementary Table 1 – Relative abundance of Phila observed in fresh samples: frozen at – 20 ºC; - 80 ºC; guanidine at 4 ºC 














Bacteroidetes 42.80 36.20 39.80 47.30 44.20 0.630
Firmicutes 50.80 58.80 54.90 45.60 47.10 0.447
Preotobacteria 2.80 2.20 2.20 3.80 4.30 0.019 0.095
Fusobacteria 1.60 0.40 0.50 1.10 1.70 0.935
Actinobacteria 1.40 2.00 2.10 1.30 2.00 0.631
Outros 0.60 0.40 0.50 0.90 0.70
p: p value obtained from Kruskal Wallis test; pc: p value corrected by Bonferroni for multiple tests.
Supplementary Table 2 – Relative abundance of main Classes observed in fresh samples:frozen at -20 ºC; -80 ºC; guanidine at 














Clostridia 47.66 54.65 51.18 43.01 44.58 0.512
Bacteroidia 42.79 36.17 39.76 47.32 44.16 0.630
Erysipelotrichi 2.53 3.26 3.05 2.01 1.91 0.337
Betaproteobacteria 1.64 0.81 0.91 2.81 2.83 0.004 0.044
Fusobacteriia 1.61 0.39 0.52 1.14 1.65 0.975
Gammaproteobacteria 0.71 0.88 0.75 0.36 0.53 0.893
Bacilli 0.64 0.86 0.71 0.59 0.57 0.789
Mollicutes 0.35 0.37 0.33 0.41 0.33 0.970
Deltaproteobacteria 0.28 0.33 0.43 0.38 0.63 0.687
Alphaproteobacteria 0.20 0.15 0.12 0.28 0.35 0.837
Lentisphaeria 0.12 0.01 0.01 0.33 0.38 0.116
Outros 1.47 2.12 2.23 1.36 2.08
p: p value obtained from Kruskal Wallis test; pc: p value corrected by Bonferroni for multiple tests.
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Supplementary Table 3 - Relative abundance of main Families observed in fresh samples: frozen at -20 ºC; -80 ºC; guanidine at 















Bacteroidaceae 31.36 27.55 29.75 33.85 32.64 0.895
Lachnospiraceae 23.50 29.77 28.40 17.04 19.11 0.213
Ruminococcaceae 18.76 18.22 16.55 20.62 19.74 0.930
Prevotellaceae 6.85 4.49 4.42 8.43 6.55 0.999
Erysipelotrichaceae 2.53 3.26 3.05 2.01 1.91 0.337
Paraprevotellaceae 1.70 1.54 2.63 1.71 1.70 0.984
Alcaligenaceae 1.63 0.80 0.90 2.80 2.82 0.003 0.054
Bifidobacteriaceae 1.35 1.95 2.00 1.22 1.90 0.968
Porphyromonadaceae 0.89 0.82 1.06 0.74 0.75 0.560
Odoribacteraceae 0.85 0.67 0.66 1.01 1.15 0.293
Clostridiaceae 0.83 0.83 0.62 0.58 0.45 0.907
Veillonellaceae 0.83 1.50 1.24 0.67 0.52 0.609
Enterobacteriaceae 0.57 0.77 0.66 0.26 0.42 0.859
Rikenellaceae 0.45 0.39 0.49 0.55 0.49 0.971
Barnesiellaceae 0.39 0.36 0.38 0.56 0.46 0.807
Streptococcaceae 0.35 0.55 0.46 0.25 0.29 0.521
Desulfovibrionaceae 0.28 0.33 0.43 0.38 0.63 0.687
Christensenellaceae 0.11 0.10 0.12 0.07 0.11 0.941
Outros 6.77 6.10 6.18 7.25 8.36 -
p: p value obtained from Kruskal Wallis test; pc: p value corrected by Bonferroni for multiple tests.
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Supplementary Table 4 - Relative abundance of main Genera observed in fresh samples: frozen at – 20 ºC; - 80 ºC;guanidine at 















Bacteroides 31.36 27.55 29.75 33.85 32.63 0.630
Faecalibacterium 8.86 6.87 6.45 10.93 9.84 0.305
Prevotella 8.19 5.64 6.63 9.89 7.91 0.999
Ruminococcus 5.65 6.64 5.47 3.31 4.12 0.897
Blautia 3.92 5.86 5.47 2.56 3.39 0.336
Coprococcus 2.05 2.34 2.26 1.43 1.39 0.230
Roseburia 1.98 2.39 2.31 1.69 1.45 0.992
Lachnospira 1.70 1.31 1.23 1.35 1.47 0.585
Sutterella 1.63 0.80 0.90 2.80 2.82 0.001 0.111
Fusobacterium 1.61 0.39 0.52 1.14 1.65 0.935
Bifidobacterium 1.35 1.95 2.00 1.22 1.90 0.971
Dorea 0.92 1.40 1.26 0.74 0.87 0.259
Parabacteroides 0.89 0.82 1.06 0.74 0.75 0.560
Dialister 0.66 1.27 1.05 0.59 0.38 0.893
Eubacterium 0.60 0.45 0.38 0.46 0.41 0.496
Odoribacter 0.50 0.38 0.40 0.68 0.73 0.191
Oscillospira 0.47 0.43 0.48 0.46 0.70 0.834
Catenibacterium 0.35 0.40 0.23 0.18 0.24 0.974
Butyricimonas 0.35 0.29 0.26 0.33 0.41 0.421
Paraprevotella 0.35 0.38 0.41 0.24 0.32 0.957
Streptococcus 0.33 0.52 0.44 0.23 0.27 0.478
Anaerostipes 0.21 0.17 0.17 0.18 0.16 0.974
Bilophila 0.17 0.22 0.31 0.19 0.35 0.644
Lactobacillus 0.17 0.13 0.09 0.21 0.12 0.938
Haemophilus 0.14 0.08 0.08 0.07 0.07 0.979
Desulfovibrio 0.11 0.10 0.12 0.18 0.28 0.942
Others 25.48 31.22 30.27 24.35 25.37
p: p value obtained from Kruskal Wallis test; pc: p value corrected by Bonferroni for multiple tests.
